Navigation Links
JDRF announces 2008 Spring Research Review Award
Date:5/22/2008

The Juvenile Diabetes Research Foundation recently awarded its top honors to three noted scientists. The awards were presented at the 2008 Spring Research Review Awards Dinner.

The David Rumbough Award for Scientific Excellence was established in 1974 by the actress Dina Merrill, in honor of her late son, David. It is the highest honor JDRF awards, and is presented annually to researchers for outstanding achievement and commitment to diabetes research and for their service to JDRF. Michael Brownlee, MD, and Michael German, MD, received the 2008 Rumbough Award.

The Gerold & Kayla Grodsky Basic Research Scientist Award is presented annually to a basic research scientist who has made outstanding contributions to diabetes research. JDRF established the award in 1993 to honor the contributions of Dr. Grodsky's diabetes research at University of California at San Francisco (UCSF) over four decades. This years recipient is Maike Sander, MD.

Of the presentation, Dina Merrill said she was honored to join with you tonight in the presentation of the David Rumbough Award for Scientific Excellence, which was established in honor of my late, beloved son, David. He would have been very pleased to know that research towards a cure is progressing rapidly and improving the lives of so many. Keep up the good work.

Michael Brownlee, MD, the Anita and Jack Saltz Professor of Diabetes Research at Albert Einstein College of Medicine is one of the most respected and influential scientists in his field. He is noted for his innovative approach to understanding the biochemical basis of diabetic complications. Internationally recognized for his research, Dr. Brownlee discovered a novel molecular pathway linking hyperglycemia to diabetic retinopathy, a complication of the disease.

Dr. Brownlee is also the Director of the JDRF International Center for Diabetic Complications Research. All of the projects in this Center share an overriding aim: to develop innovative, highly effective therapies for preventing the development and progression of retinopathy, nephropathy, neuropathy, and atherosclerosis in type 1 patients. In 2006, JDRF awarded Dr. Brownlee with the Scholar Award.

His other scientific awards include the American Diabetes Associations Banting Medal and Outstanding Scientific Achievement Award, the European Association for the Study of Diabetes Claude Bernard Medal, Columbia Universitys Naomi Berrie Award, and Duke University Medical Schools Distinguished Alumnus Award.

Michael German, MD, is a Professor in the Department of Medicine at UCSF, Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the Hillblom Islet Genesis Network and the UCSF NIH Diabetes and Endocrinology Research Center (DERC), and a Principle Investigator in the Hormone Research Institute. Understanding the structure and development of pancreatic beta cells is the main focus of Dr. Germans research. He is the recipient of three other awards given by JDRF: the Scholar Award (2007), Living and Giving Award (2004), and Career Development Award (1991-1994).

Maike Sander, MD, Associate Professor in the Department of Developmental & Cell Biology at the School of Biological Sciences at the University of California at Irvine and the recipient of the Grodsky Award, is committed to understanding the importance of a specific class of factors for the development and function of the insulin-producing cells in the pancreas. She is also a recipient of the JDRF Career Development Award (2001-2006).


'/>"/>

Contact: Jillian Lubarsky
jlubarsky@jdrf.org
212-479-7626
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: